Quinn Opportunity Partners LLC Viatris Inc Transaction History

Quinn Opportunity Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.27 - $13.53 $22,540 - $27,060	2,000 Added 6.21%	34,220 $408,000
Q2 2023 Aug 11, 2023	SELL	$9.02 - $10.29 $151,536 - $172,872	-16,800 Reduced 34.27%	32,220 $321,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $427,454 - $566,671	49,020 New	49,020 $545,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $37,142 - $48,749	-4,380 Reduced 8.2%	49,020 $418,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $98,100 - $154,000	-10,000 Reduced 15.77%	53,400 $581,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $9,672 - $11,744	800 Added 1.28%	63,400 $858,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $10,600 - $12,104	-800 Reduced 1.26%	62,600 $848,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $906,620 - $1.19 Million	63,400 New	63,400 $1.19 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quinn Opportunity Partners LLC with notifications on news.